AdvanceCOR

Developer of drugs and diagnostics for cardiovascular diseases. The company's lead candidate is "Revacept", a therapeutic agent used to prevent and treat acute arterial thrombosis that can lead to heart attack and stroke. Also, it is developing GPVI-inhibiting antibodies to inhibit the attachment of platelets to the wall of a blood vessel.